Kestra Medical Technologies, Ltd. KMTS
27.14
1.38
5.36%
as of 25 Sep
- Market cap
- $1.5B
- P/E
- 0.0×
Follow KMTS
Insider Buys
alert about insiders buying in the last 12 month
| Jul '26 | Apr '26 | Jan '26 | Oct '25 | Older periods | |
|---|---|---|---|---|---|
| (73.74%) | (56.60%) | (366.07%) | 0.00% |
+6 more TTM periods Free account |
|
| (48.85%) | (40.24%) | (75.86%) | (109.08%) | ||
ROIC |
(93.49%) | (79.54%) | (235.95%) | (271.86%) | |
Return on Tangible Assets |
(62.02%) | (56.96%) | (44.28%) | (65.45%) | |
Average Days of Receivables |
52.69 | 55.80 | 55.41 | 51.18 | |
Free Cash Flow per Share |
(2.10) | (2.16) | (2.15) | (2.22) | |
Free Cash Flow |
(123.06) | (116.94) | (120.01) | (114.18) | |
Capital Expenditures |
(35.34) | (35.24) | (32.97) | (27.51) | |
Piotroski F-Score |
3.00 | 4.00 | 1.00 | 1.00 | |
| Other line items | |||||
Cash ROIC |
(17.77%) | (16.38%) | (14.00%) | (22.73%) | |
Accounts Receivable Turnover |
8.66 | 8.41 | 11.39 | 0.00 | |
Accounts Payable Turnover |
2.21 | 1.81 | 1.79 | 0.00 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
192.53 | 215.35 | 204.36 | 185.32 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
20.87% | 20.48% | 26.98% | 28.24% | |
Selling, General and Administrative Expense of Revenue |
167.49% | 172.53% | 197.31% | 196.99% | |
Share Based Compensation of Revenue |
36.15% | 35.37% | 54.53% | 48.48% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.59 | 0.62 | 0.60 | 0.64 | |
Depreciation/Fixed assets |
0.16 | 0.18 | 0.19 | 0.21 | |
Capex/Depreciation |
(3.48) | (3.36) | (3.30) | (2.86) | |
Revenue per Share |
1.82 | 1.76 | 1.50 | 1.45 | |
Operating CF per Share |
(1.50) | (1.51) | (1.56) | (1.69) | |
Capex per Share |
(0.60) | (0.65) | (0.59) | (0.54) | |
Capex to Sales |
0.33 | 0.37 | 0.39 | 0.37 | |
Net Profit Margin |
(140.43%) | (138.36%) | (171.87%) | (181.20%) |
Columns are period end dates